Table 4.
Variables (initial model) | Adjusted odds ratio 120 day MACE or death |
Beta-coefficient | P-value |
---|---|---|---|
Chest pain or dyspnoea | 2.2 (1.2–4.1) | 0.799 | 0.01 |
New or presumably new ECG changes | 1.3 (0.7–2.5) | 0.279 | 0.375 |
Troponin delta +1 to <2x 99th percentile | Reference | Reference | |
ȃTroponin delta +2–4x 99th percentile | 2.2 (1.3–3.5) | 0.77 | 0.002 |
ȃTroponin delta +>4x 99th percentile | 1.7 (1.0–2.9) | 0.529 | 0.051 |
ESC/ESA surgical risk <1% | Reference | Reference | |
ȃESC/ESA surgical risk 1%–5% | 1.1 (0.6–2.0) | 0.071 | 0.816 |
ȃESC/ESA surgical risk >5% | 2.8 (1.4–5.6) | 1.024 | 0.005 |
Urgency: elective | Reference | Reference | |
ȃUrgency: < 24 h | 2.6 (1.5–4.4) | 0.938 | <0.001 |
ȃUrgency: 2–7 days | 2.4 (1.4–4.0) | 0.863 | <0.001 |
Post-operative bleeding | 0.5 (0.3–0.8) | −2.565 | 0.005 |
Derivation of risk prediction model for MACEs and all-cause death within 120 days following perioperative myocardial infarction/injury likely due to type 2 myocardial infarction using logistic binary regression model, incorporating perioperative variables available at time of detection of likely due to type 2 myocardial infarction-perioperative myocardial infarction/injury.
ECG, electrocardiogram; ESA, European Society of Anaesthesiology; ESC, European Society of Cardiology; MACE, major adverse cardiac event.